Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975–1995
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
A multicenter study for monitoring antimicrobial drug resistance in clinical isolates of the familyEnterobacteriaceae, Pseudomonas aeruginosa, Staphylococcus andEnterococcus species in central Europa conducted by the Study Group Bacterial Resistance of the Paul-Ehrlich-Society for Chemotherapy has been ongoing since 1975. Between 1975 and 1995 susceptibility data on almost 60,000 bacteria, which were isolated and sampled under a common protocol by laboratories from Austria, Germany and Switzerland, were collected. These bacterial isolates were known by the respective investigators to have caused infections. From 1975 to the mid-80s none of the bacterial species examined showed an increase in resistance. The frequency of resistance in klebsiellae andStaphylococcus aureus to some antibiotics even declined. In 1990 and particularly in 1995, a clear increase in resistance for a number of antibiotic-organism pairs was observed. Resistance rates of fluoroquinolones increased in all species under investigation. InEscherichia coli the increase of resistance to ampicillin, co-trimoxazole and gentamicin was remarkable. Resistance to imipenem increased inP. aeruginosa. Resistance to cephalosporins, on the other hand, remained largely unchanged in gram-negative bacilli. Between 1990 and 1995, the prevalence of oxacillin resistance increased from 1.7 to 12.9% inS. aureus and from 15.8 to 55.8% in coagulase-negative staphylococci, whereas staphylococcal and enterococcal resistance to glycopeptides was still rare.
- Gold, H. S., Moellering, R. C., Jr. Antimicrobial-drug resistance. N. Engl. J. Med. 335 (1996) 1445–1453. CrossRef
- Tenover, F. C., Hughes, J. M.: The challenge of emerging infectious diseases—development and spread of multiply-resistant bacterial pathogens. JAMA 275 (1996) 300–304. CrossRef
- Lederberg, J., Shope, R. E., Oaks, S. C. Jr. (eds.): Emerging infections: microbial threats to health in the United States. National Academy Press, Washington, D.C. 1992.
- Kresken, M., Wiedemann, B.: Die Epidemiologie der Resistenz bei Bakterien und ihre-Bedeutung für die Wirksamkeit von Chemotherapeutika. Fortschr. Antimikrob. Antineoplast. Chemother. 6–6 (1987) 869–1063.
- DIN Deutsches Institut für Normung e. V.: Methoden zur Empfind-lichkeitsprüfung von mikrobiellen Krankheitserregern gegen Chemotherapeutika. DIN 58940, Teil 3—Beiblatt 1 und Teil 4—Beiblatt 1. Beuth Verlag, Berlin 1998.
- Du Bois, S. K., Marriott, M. S., Amyes, S. G. B.: TEM- and SHV-derived extended β-lactamases: relationship between selection, structure and function. J. Antimicrob. Chemother. 35 (1995) 7–22. CrossRef
- Monnet, D. L., Archibald, L. K., Phillips, L., Tenover, F. C., McGowan, J. E. Jr., Gaynes, R. P., the Intensive Care Antimicrobial Resistance Epidemiology Project and the National Infections Surveillance System Hospitals: Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modelling. Infect. Control Hosp. Epidemiol. 19 (1998) 388–394. CrossRef
- Feinman, S.: Antibiotics in animal feed—drug resistance revisited. ASM News 64 (1998) 24–30.
- Drug resistance among clinical isolates of frequently encountered bacterial species in central Europe during 1975–1995
Volume 27, Issue 2 Supplement, pp S2-S8
- Cover Date
- Print ISSN
- Online ISSN
- Urban & Vogel
- Additional Links
- Industry Sectors